The first and Only Technology enabling 2-day Therapy Selection
We’ve cracked the code on developing personalized therapy guidance by measuring cell weight change, not cell death.
We Focus on Cancer Cell Weight Change
While it takes days or weeks to measure cell death, cell weight change can be measured in hours.
Our proprietary technology, developed at the Massachusetts Institute of Technology (MIT), measures a patient's live tumor cells' mass response (weight change) to cancer drugs or drug combinations in hours.
We can weigh single cells 100 times more precisely than alternative technologies. This extraordinary precision enables us to detect when a cell begins responding to a drug long before it dies.
Travera predicts which cancer drugs are likely or unlikely to work for your patient. The weight change occurs regardless of an effective drug's mechanism of action; if a cancer drug does not affect the weight of cancer cells, it’s unlikely it will help the patient.
A Clear Path to Personalized Cancer Therapy
Our Rapid Therapy Selection™ test overcomes previous biological and clinical barriers to personalized cancer therapy. Past efforts have focused on measuring cell death, a process that can take over a week and has shown no sustainable clinical success. Since a cell’s weight change ex vivo happens in hours, we eliminate the difficulty of having to distinguish between natural cell death and cell death induced by a cancer drug.
Preliminary studies have shown that Travera’s Rapid Therapy Selection™ test applies to many different cancer drugs with different mechanisms of action across 90% of cancers.
Contact Us
Travera offers email and phone support (781-874-0808) services to address any questions about the test, technology, process, or use of the report information. Don't hesitate to contact us anytime; we will respond within 24 hours.